Key facts
- BluumBio’s last known valuation is $1.8M (Jan 2021).
- It has raised $130K; the latest was Seed Round in May 2025.
- Notable investors include Plug and Play Tech Center, Y Combinator, Liquid 2 Ventures, University of California, Activate Global — 17 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for BluumBio
- ·The full record, as it builds
Funding rounds
No funding rounds for BluumBio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BluumBio
Developer of a bio-based remediation technology designed to remove toxic industrial chemicals from the environment and manufacturing waste streams. The company's technology combines enzyme discovery, enzyme optimization, and host engineering to create bacteria and plants that can remove industrial chemicals from contaminated sites, enabling clients to develop new enzymes to clean up the planet while saving time and money.
- Sector
- Business Products and Services (B2B)
- HQ
- Berkeley, CA, United States
- Founded
- 2021
- Employees
- 7
- Website
- bluumbio.com/
- Ownership
- Privately Held (backing)
BluumBio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BluumBio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BluumBio in its N-PORT filings yet. We sweep new filings monthly.